GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Buildings And Improvements

Amicogen (XKRX:092040) Buildings And Improvements : ₩99,879 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Buildings And Improvements?

Amicogen's quarterly buildings and improvements declined from Sep. 2024 (₩120,587 Mil) to Dec. 2024 (₩99,879 Mil) but then stayed the same from Dec. 2024 (₩99,879 Mil) to Mar. 2025 (₩99,879 Mil).

Amicogen's annual buildings and improvements increased from Dec. 2022 (₩47,509 Mil) to Dec. 2023 (₩48,175 Mil) and increased from Dec. 2023 (₩48,175 Mil) to Dec. 2024 (₩99,879 Mil).


Amicogen Buildings And Improvements Historical Data

The historical data trend for Amicogen's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Buildings And Improvements Chart

Amicogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,277.92 33,467.44 47,508.80 48,174.97 99,879.31

Amicogen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48,429.67 120,917.94 120,587.04 99,879.31 99,879.31

Amicogen Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Amicogen Business Description

Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.

Amicogen Headlines

No Headlines